|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-10-18
|
|
pubmed:abstractText |
Sodium antimony gluconate (SAG) is reported to be losing its efficacy in Bihar as a first line drug for treatment of visceral leishmaniasis (VL). Concerned with the increasing incidence of antimony-resistant VL patients in Bihar, we undertook an epidemiological, clinical and pharmacological study to formulate a scientific basis for choosing a suitable first line drug for VL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0971-5916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
120
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
166-72
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15489554-Adult,
pubmed-meshheading:15489554-Amphotericin B,
pubmed-meshheading:15489554-Analysis of Variance,
pubmed-meshheading:15489554-Animals,
pubmed-meshheading:15489554-Antimony,
pubmed-meshheading:15489554-Antimony Sodium Gluconate,
pubmed-meshheading:15489554-Antiprotozoal Agents,
pubmed-meshheading:15489554-Child,
pubmed-meshheading:15489554-Drug Resistance,
pubmed-meshheading:15489554-Humans,
pubmed-meshheading:15489554-India,
pubmed-meshheading:15489554-Leishmaniasis, Visceral,
pubmed-meshheading:15489554-Male,
pubmed-meshheading:15489554-Mice,
pubmed-meshheading:15489554-Mice, Inbred BALB C,
pubmed-meshheading:15489554-Spectrophotometry, Atomic
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
|
|
pubmed:affiliation |
Balaji Utthan Sansthan & Rajendra Memorial Research Institute of Medical Sciences, Patna, India. cpthakur@sancharnet.in
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
